Zobrazeno 1 - 1
of 1
pro vyhledávání: ''
Autor:
Marie-Ange Mouret-Reynier, C. Abrial, Xavier Durando, F. Kwiatkowski, Philippe Chollet, M. Leheurteur, Jean-Pierre Ferriere, Hervé Curé, A. Cabrespine, Frédérique Penault-Llorca
Publikováno v:
Scopus-Elsevier
Metastatic breast cancer (MBC) is incurable in most cases. While multiple treatments are available, the median survival is still approximately 2 years. We planned to assess the apparent impact of taxanes and aromatase inhibitors (letrozole, anastrozo